Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
The Lancet. Oncology|December 16, 2014
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trialCora N Sternberg, Iwona Skoneczna, J Martijn Kerst, et al.Computers in Biology and Medicine|July 11, 2021
A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapyMahmoud Aldraimli, Daniele Soria, Diana Grishchuck, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2012
Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicityGillian C Barnett, Rebecca M Elliott, Jan Alsner, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2022
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE studyPhilipp Heumann, Miguel E Aguado-Barrera, Barbara Avuzzi, et al.Breast (Edinburgh, Scotland)|January 17, 2026
Breast composition and dose deposition to fat and fibroglandular tissues are associated with breast side effects after radiation therapyTanwiwat Jaikuna, Fiona Wilson, Carmel Anandadas, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 2015
XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer PatientsPetra Seibold, Sabine Behrens, Peter Schmezer, et al.Frontiers in Oncology|November 20, 2020
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast CohortTim Rattay, Petra Seibold, Miguel E Aguado-Barrera, et al.Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2014
A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicityGillian C Barnett, Deborah Thompson, Laura Fachal, et al.Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.Pageof 5